Benutzer: Gast  Login
Dokumenttyp:
journal article 
Autor(en):
Saussele, S; Lauseker, M; Gratwohl, A; Beelen, DW; Bunjes, D; Schwerdtfeger, R; Kolb, HJ; Ho, AD; Falge, C; Holler, E; Schlimok, G; Zander, AR; Arnold, R; Kanz, L; Dengler, R; Haferlach, C; Schlegelberger, B; Pfirrmann, M; Müller, MC; Schnittger, S; Leitner, A; Pletsch, N; Hochhaus, A; Hasford, J; Hehlmann, R; German CML Study Group 
Titel:
Allogeneic hematopoietic stem cell transplantation (allo SCT) for chronic myeloid leukemia in the imatinib era: evaluation of its impact within a subgroup of the randomized German CML Study IV. 
Abstract:
The role of allogeneic stem cell transplantation in chronic myeloid leukemia is being reevaluated. Whereas drug treatment has been shown to be superior in first-line treatment, data on allogeneic hematopoietic stem cell transplantation (allo SCT) as second-line therapy after imatinib failure are scarce. Using an interim safety analysis of the randomized German CML Study IV designed to optimize imatinib therapy by combination, dose escalation, and transplantation, we here report on 84 patients wh...    »
 
Zeitschriftentitel:
Blood 
Jahr:
2010 
Band / Volume:
115 
Heft / Issue:
10 
Seitenangaben Beitrag:
1880-5 
Sprache:
eng 
Print-ISSN:
0006-4971 
TUM Einrichtung:
III. Medizinische Klinik und Poliklinik